Home › Macular Degeneration › Oregon › Eugene
Macular Degeneration clinical trials in Eugene, OR
4 studies for Macular Degeneration are looking for participants at sites in and around Eugene (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RecruitingPhase 3
- Verum Research LLC, Eugene
- Cascade Medical Research Institute LLC, Springfield · 3 mi away
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RecruitingPhase 2/3
- Verum Research LLC, Eugene
- Cascade Medical Research Institute, LLC, Springfield · 3 mi away
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
RecruitingPhase 1/2
- Verum Research, LLC, Eugene
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
RecruitingPhase 2/3
- Cascade Medical Research Institute, LLC, Springfield · 3 mi away
About Macular Degeneration
Macular degeneration, or age-related macular degeneration (AMD), is the leading cause of vision loss in older adults. Learn about the types and what might help.
More about Macular Degeneration on MedlinePlus
Macular Degeneration trials in other cities
- Dallas, TX12 studies
- Erie, PA9 studies
- The Woodlands, TX9 studies
- Sacramento, CA7 studies
- Carmel, IN7 studies
- Santa Monica, CA7 studies
- Hagerstown, MD7 studies
- Houston, TX7 studies
- Phoenix, AZ7 studies
- McAllen, TX7 studies
- Cleveland, OH7 studies
- Reno, NV7 studies
Other studies in Eugene
- Non-Small Cell Lung Cancer11 studies
- Ovarian Cancer10 studies
- Endometrial Cancer8 studies
- Metastatic Cancer6 studies
- Breast Cancer6 studies
- Cancer (all types)6 studies
- Multiple Myeloma6 studies
- Chronic Lymphocytic Leukemia6 studies
- Drug Use and Addiction5 studies
- Obesity4 studies
- Lung Cancer4 studies
- Overweight3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.